Key result
Tigertriever linked to ~3-fold higher modified first-pass effect vs standard stent retrievers in stroke.
Why the study?
Does the Tigertriever improve the modified first-pass effect compared to self-expanding stent retrievers in patients with acute ischemic stroke due to anterior circulation large-vessel occlusion?
Cohort (n=103)
No
Does the Tigertriever improve the modified first-pass effect compared to self-expanding stent retrievers in patients with acute ischemic stroke due to anterior circulation large-vessel occlusion?
Answers are grounded in this paper and cite their sources.
The Tigertriever device may achieve a higher rate of successful reperfusion on the first pass compared to standard self-expanding stent retrievers in acute ischemic stroke.
Stent retrievers, including the novel Tigertriever, are important in mechanical thrombectomy for acute ischemic stroke due to a proximal large-vessel occlusion within the anterior circulation. We aimed to assess the efficacy and safety of the Tigertriever compared to self-expanding stent retrievers like EmboTrap, Solitaire, Trevo, or Tron. Patients treated at a stroke center for intracranial vessel occlusion in the anterior circulation between August 2022 and August 2024 were evaluated. The primary outcome was a modified first-pass effect, defined as a modified thrombolysis in cerebral infarction grade of 2b-3 after the first pass. Secondary outcomes included the first-pass effect, device-related serious adverse events, embolization in new territory, and hemorrhagic complications within 24 hours post-procedure. Data from 104 hemispheres in 103 patients were analyzed (24 in the Tigertriever group and 80 in the stent-retriever group). The Tigertriever group demonstrated a higher modified first-pass effect (70.8% vs. 52.5%; adjusted odds ratio 3.17; 95% confidence interval 1.06-9.47; p = 0.02). Although not statistically significant, vessel dissection (0% vs. 3.8%), subarachnoid hemorrhage (20.8% vs. 32.5%), and symptomatic intracranial hemorrhage (4.2% vs. 12.5%) within 24 hours post-procedure were lower in the Tigertriever group. No significant differences were observed in the first-pass effect or embolization in the new territory between the 2 groups. The Tigertriever might be effective for anterior circulation intracranial vessel occlusion, achieving a higher rate of modified first-pass effect. It might also be associated with minimal serious procedural complications, indicating its safety profile.
No takes yet. Share an insight, caveat, or question.
Shindo et al. (2025) conducted a cohort in Acute ischemic stroke (n=103). Tigertriever vs. Self-expanding stent retrievers (EmboTrap, Solitaire, Trevo, or Tron) was evaluated on Modified first-pass effect (modified thrombolysis in cerebral infarction grade of 2b-3 after the first pass) (adjusted OR 3.17, 95% CI 1.06-9.47, p=0.02). The Tigertriever achieved a higher modified first-pass effect compared to self-expanding stent retrievers for anterior circulation occlusion.
Synapse has enriched 10 related papers. Consider them for comparative context: